Fibralign Corporation: Fibralign Announces Start of European Lymphedema Prevention Clinical Study
Multi-site clinical study to evaluate BioBridge as prophylactic treatment for at-risk patients
Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced enrollment of the first patient in a multi-site, randomized clinical trial in Europe evaluating its BioBridge Collagen Matrix as a novel preventative treatment for secondary lymphedema.
The study plans to enroll 40 patients that have been diagnosed with advanced stage breast cancer and require axillary lymph node dissection (ALND), a common surgical intervention that involves removal of compromised lymph nodes to address the spread of cancer. Peer reviewed publications have estimated that 15-25% of patients who undergo ALND develop breast cancer-related lymphedema (BCRL) due to the surgery. ALND combined with radiation therapy increases the likelihood of BCRL further up to 40%.
endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services
SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/
endpoint Clinical, an industry-leading global interactive response technology (IRT) company, has appointed Christine Hurley as its Senior Vice President, Client Services. Bringing over 20 years of experience in clinical operations and technology, Christine will be responsible for overseeing Client Services with Account Management, Project Management, Customer Success, and Customer Support under her leadership. I am proud to join the endpoint leadership team to help continue driving their vision forward, says Christine Hurley, Sr. Vice President, Client Services. Throughout Hurley s career, she has held various roles across Clinical Operations and technology leadership and has a true passion for IRT. Leading clinical systems strategy, process improvement, and partnership strategy development, she has worked for clinical technol
ACON
A new counselling service spearheaded by ACON, Australia’s largest sexuality and gender diverse health organisation, will give LGBTQ community members more options in accessing inclusive and culturally appropriate mental health care and support.
Pride Counselling provides counselling support to LGBTQ community members seeking an affordable service.
“ACON is proud to offer this new service to our communities, which will further support and strengthen the health and wellbeing of LGBTQ people,” ACON CEO Nicolas Parkhill said.
“Pride Counselling will provide clients with the inclusive, community-level understanding that they need to help support, nurture and strengthen their overall mental health.”
Research and Markets: Global Clinical In Vitro Diagnostic Medical Laboratory Services Market Strategies & Trends Report 2021 with Q12021 Update of COVID-19 Impacts - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.
The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.
百岁医者张效房：永远站在为病人服务的第一线-中新网 chinanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinanews.com Daily Mail and Mail on Sunday newspapers.